Clinical Trial Update: A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Yangzhengxiaoji Capsule added to niraparib maintenance therapy to improve nausea in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)
• Yangzhengxiaoji Capsule

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN